Pharmacological and chemical properties of astressin, antisauvagine-30 and α-helCRF: significance for behavioral experiments
- 1 September 2001
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 41 (4) , 507-516
- https://doi.org/10.1016/s0028-3908(01)00094-6
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The First Extracellular Domain of Corticotropin Releasing Factor-R1 Contains Major Binding Determinants for Urocortin and AstressinEndocrinology, 1998
- Corticotropin-Releasing Factor (CRF) Family of Ligands and Their ReceptorsThe Endocrinologist, 1997
- The Significance of Artificial Cerebrospinal Fluid as Perfusate and EndoneurosurgeryNeurosurgery, 1996
- Corticotrophin-releasing factor receptors: from molecular biology to drug designTrends in Pharmacological Sciences, 1996
- Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factorNature, 1995
- How we describe competitive antagonists: three questions of usageTrends in Pharmacological Sciences, 1991
- Synthetic Competitive Antagonists of Corticotropin-Releasing Factor: Effect on ACTH Secretion in the RatScience, 1984
- The distribution of corticotropin releasing factor-like immunoreactive neurons in rat brainPeptides, 1982
- Corticotropin releasing factor produces behavioural activation in ratsNature, 1982
- How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?Journal of Pharmacy and Pharmacology, 1978